BioWednesday Stevenage

BioWednesday Stevenage: Road to Success - Navigating the Innovation Pipeline in Therapeutics

We are delighted to be hosting this BioWednesday event at Stevenage Bioscience Catalyst.

The focus is to explore the latest advancements in therapeutics and discuss the regulatory and practical challenges and opportunities along the innovation pipeline.

…and there will be pizza!

Agenda

12:30 - Registration and pizza lunch

13.00 - SBC companies showcase 

Autolus (Claudia Mayer, VP and Head of Nucleus Site Delivery and Cell Manufacturing)

Laverock Therapeutics (David Venables, CEO)

Neobe Therapeutics (Pedro Correa de Sampaio, CEO)

NeRRe Therapeutics (Mary Kerr, CEO)

NRG Therapeutics (TBC) 

14.00 – Break

14.30 - Panel Discussion “Road to Success - Navigating the Innovation Pipeline in Therapeutics"

Speakers:

Marco Delise, Entrepreneurship & Business Development Director at Stevenage Bioscience Catalyst (Moderator)

Mai Yee Mishir, Senior Director of Global Regulatory Affairs at Advanced Clinical

Charles Large, CEO at Autifony

James Moon, Professor of Cardiology at UCL, CMR lead at Barts Heart Centre and CEO at Mycardium AI

15.30 - Networking and drinks

17.00 - Close

Prices
Members: Free
Non-members: £50 +VAT
Academics: please contact jasmin@onenucleus.com